Medtronic receives FDA clearance for new InPen app

Medtronic has announced U.S. Food and Drug Administration (FDA) clearance for its new InPen app featuring missed meal dose detection, paving the way for the launch of its Smart MDI system with the Simplera continuous glucose monitor (CGM).